Showing results (1-10 of 26) with videos related to

Sort By:
Pageof 3
Molecular & Cellular Oncology|June 17, 2016
Diagnostic implications of intrapatient genetic tumor heterogeneityAna P Berbegall, Samuel Navarro, Rosa Noguera
Pediatric Blood & Cancer|January 26, 2017
A stiff extracellular matrix is associated with malignancy in peripheral neuroblastic tumorsIrene Tadeo, Ana P Berbegall, Samuel Navarro, et al.
Frontiers in Oncology|March 14, 2014
Biotensegrity of the extracellular matrix: physiology, dynamic mechanical balance, and implications in oncology and mechanotherapyIrene Tadeo, Ana P Berbegall, Luis M Escudero, et al.
Histology and Histopathology|November 24, 2017
1p36 deletion results in a decrease in glycosaminoglycans which is associated with aggressiveness in neuroblastic tumorsIrene Tadeo, Esther Gamero-Sandemetrio, Ana P Berbegall, et al.
Neoplasia (New York, N.Y.)|August 1, 2014
Neuroblastoma after childhood: prognostic relevance of segmental chromosome aberrations, ATRX protein status, and immune cell infiltrationAna P Berbegall, Eva Villamón, Irene Tadeo, et al.
British Journal of Cancer|July 15, 2016
Extracellular matrix composition defines an ultra-high-risk group of neuroblastoma within the high-risk patient cohortIrene Tadeo, Ana P Berbegall, Victoria Castel, et al.
Computers in Biology and Medicine|January 8, 2013
NeuPAT: an intranet database supporting translational research in neuroblastic tumorsEva Villamón, Marta Piqueras, Javier Meseguer, et al.
Cancers|October 23, 2021
Intra-Tumour Genetic Heterogeneity and Prognosis in High-Risk NeuroblastomaAmparo López-Carrasco, Ana P Berbegall, Susana Martín-Vañó, et al.
Plos One|January 24, 2013
Genetic instability and intratumoral heterogeneity in neuroblastoma with MYCN amplification plus 11q deletionEva Villamón, Ana P Berbegall, Marta Piqueras, et al.
Pageof 3